Standout Papers

Ivabradine and outcomes in chronic heart failure (SHIFT): a random... 2003 2026 2010 2018 1.7k
  1. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study (2010)
    Karl Swedberg, Michel Komajda et al. The Lancet
  2. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) (2005)
    Karl Swedberg, John G.F. Cleland et al. European Heart Journal
  3. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction (2008)
    Barry M. Massie, Peter E. Carson et al. New England Journal of Medicine
  4. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial (2003)
    Philip A. Poole‐Wilson, Karl Swedberg et al. The Lancet
  5. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure (2020)
    Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine
  6. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial (2009)
    Philip Home, Stuart Pocock et al. The Lancet
  7. Hypertrophic Cardiomyopathy (2003)
    Pascale Richard, Philippe Charron et al. Circulation
  8. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial (2010)
    Michael Böhm, Karl Swedberg et al. The Lancet
  9. The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment (2003)
    Michel Komajda European Heart Journal
  10. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial (2009)
    Marvin A. Konstam, James D. Neaton et al. The Lancet
  11. Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction (2020)
    Milton Packer, Stefan D. Anker et al. Circulation
  12. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial (2021)
    Milton Packer, Javed Butler et al. Circulation

Immediate Impact

9 by Nobel laureates 8 from Science/Nature 104 standout
Sub-graph 1 of 17

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
1 intermediate paper

Works of Michel Komajda being referenced

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
2020 Standout
Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene
2005

Author Peers

Author Last Decade Papers Cites
Michel Komajda 21729 3815 4111 349 26.1k
Akshay S. Desai 16262 1561 4472 379 20.2k
Javed Butler 11041 2128 2599 398 15.3k
Inder S. Anand 17182 1578 2573 412 22.5k
Carolyn S.P. Lam 21375 2958 5745 555 28.3k
Mihai Gheorghiade 18289 3441 2413 408 25.4k
Willem J. Remme 15792 2218 6530 153 20.4k
Heribert Schunkert 12939 3790 3435 594 19.9k
Wiek H. van Gilst 11707 3648 2395 476 20.5k
Robert Cody 12752 1900 4210 150 17.0k
Brian Claggett 11841 1458 3761 536 18.4k

All Works

Loading papers...

Rankless by CCL
2026